About PharmaVerse

We work alongside KMC Healthcare, a team of highly skilled consultants to the health care sector, specialising in the provision and reimbursement of pharmaceuticals in Australia, New Zealand, Asia and Europe. They have been advising the pharmaceutical sector since 2000, representing clients from the largest multinational manufacturers and suppliers to wholesalers and community pharmacy, as well as their representative organisations. Their expert team delivers Health Technology Assessment, PBAC and MSAC submissions, PHARMAC submissions, economic modelling and client-focused commercialisation strategies, complementing PharmaVerse’s medical affairs and launch capabilities.

Sajni brings over 15 years of expertise in evidence synthesis, systematic reviews, and methodology design in the field of biotech consulting in Australia. She skillfully identifies areas of unmet need by utilizing scientific data to pinpoint critical gaps and opportunities that are essential for healthcare decision-making. Sajni excels in translating complex data into decision-ready outputs for funders, providers, policymakers, and governments, thereby enhancing healthcare access strategies. Her work supports guidelines, education, and policy development, equipping clients with the medical affairs solutions necessary for implementing effective access strategies.

Caroline has over 20 years of experience delivering excellence in medical affairs and team leadership, primarily within the pharmaceutical industry, including renowned companies like Eli Lilly, Novartis, and Sanofi. As the Director of Markey Medical Consulting, she specializes in biotech consulting in Australia, focusing on specialty care and rare diseases throughout all stages of the product life cycle—from clinical trials to market access, launch preparedness, and medical education. Caroline is particularly adept at developing effective healthcare access strategies and utilizing KOL and patient insights to shape her approach, which results in innovative medical affairs solutions that facilitate the delivery of medicines.

Caroline brings over 30 years of experience in healthcare, including senior leadership roles at Pfizer, Roche, Bayer, TEVA, and CSIRO. As an expert in biotech consulting in Australia, she focuses on commercialisation, market research, and healthcare access strategies, as well as developing effective go-to-market strategies. Her expertise encompasses crucial areas such as oncology, ophthalmology, respiratory, and infectious disease. Renowned for her sharp commercial acumen and ability to create human connections, Caroline guides teams in developing medical affairs solutions that translate scientific insights into impactful strategies.

Tim is a senior pharmaceutical executive with extensive experience in general management, drug development, and commercial strategy across Australia, the US, and Europe. His expertise includes guiding local sponsorship, R&D tax credits, and business development while focusing on healthcare access strategies. Tim's work encompasses commercialisation, go-to-market planning, access programs, reimbursement strategies, and field force planning. With specialized knowledge in transplant, immunology, oncology, and rare diseases, he provides biotech consulting in Australia, delivering strategic insights that help clients navigate complex challenges and drive growth through effective medical affairs solutions.

Feisia brings over 15 years of experience in pharma, including roles at Pfizer and AstraZeneca, as well as her consulting expertise in biotech consulting in Australia with Lucid MedComms. She specializes in healthcare access strategies and medical affairs solutions, focusing on omnichannel strategy and AI-driven innovations. These medical affairs solutions simplify the use, sharing, and application of clinical and regulatory data, empowering teams to deliver clear, compliant, and impactful content.

Jason brings over 15 years of experience in healthcare as a pharmacist, working directly with patients to understand their needs and how effective communication can support better health outcomes. He translates this expertise into the development of clear, compliant resources and company communications that connect patient needs with clinical practice. Additionally, Jason's specialization in biotech consulting Australia enables him to enhance healthcare access strategies and develop comprehensive medical affairs solutions. He prepares SOPs, reviews promotional materials, and creates resources for both healthcare professionals and patients. His approach ensures that pharmaceutical communications are relevant, effective, and empower companies to prioritize their strategic objectives.

With a background in medical lab science and research, Josephine specializes in translating complex data into accessible medical education and scientific resources. Her expertise spans diagnostics, renal, and cardiology, making her a valuable asset in biotech consulting in Australia. She is passionate about simplifying the complex for clinicians and patients—creating content that educates, engages, and drives adherence, ultimately supporting effective healthcare access strategies and tailored medical affairs solutions.